GlaxoSmithKline (GSK) has reached an agreement with the German Government to cut the country’s swine flu vaccine order by 30%, paving the way for similar agreements with other countries.

The German Government requested that the order be shortened to 34 million doses, and the UK, France, the Netherlands, Belgium and Spain are also in talks with GSK to reduce their orders as the pandemic appears to be less severe than first believed.

The desire to negotiate contracts was also sparked after it was confirmed that one single dose of the vaccine is sufficient to immunise patients rather than the two originally expected.

GSK Biologicals president Jean Stephenne said that pandemics by their nature are unpredictable and the company recognises that governments’ needs are changing.

“We are committed to finding solutions for governments changing their immunisation programmes and to fulfilling recent new orders,” Stephenne said.